These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

352 related articles for article (PubMed ID: 22707558)

  • 1. Development of dilated cardiomyopathy in Bmal1-deficient mice.
    Lefta M; Campbell KS; Feng HZ; Jin JP; Esser KA
    Am J Physiol Heart Circ Physiol; 2012 Aug; 303(4):H475-85. PubMed ID: 22707558
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiomyocyte-specific Bmal1 deletion in mice triggers diastolic dysfunction, extracellular matrix response, and impaired resolution of inflammation.
    Ingle KA; Kain V; Goel M; Prabhu SD; Young ME; Halade GV
    Am J Physiol Heart Circ Physiol; 2015 Dec; 309(11):H1827-36. PubMed ID: 26432841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy.
    Nagueh SF; Shah G; Wu Y; Torre-Amione G; King NM; Lahmers S; Witt CC; Becker K; Labeit S; Granzier HL
    Circulation; 2004 Jul; 110(2):155-62. PubMed ID: 15238456
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deleting Full Length Titin Versus the Titin M-Band Region Leads to Differential Mechanosignaling and Cardiac Phenotypes.
    Radke MH; Polack C; Methawasin M; Fink C; Granzier HL; Gotthardt M
    Circulation; 2019 Apr; 139(15):1813-1827. PubMed ID: 30700140
    [TBL] [Abstract][Full Text] [Related]  

  • 5. BMAL1 regulates mitochondrial fission and mitophagy through mitochondrial protein BNIP3 and is critical in the development of dilated cardiomyopathy.
    Li E; Li X; Huang J; Xu C; Liang Q; Ren K; Bai A; Lu C; Qian R; Sun N
    Protein Cell; 2020 Sep; 11(9):661-679. PubMed ID: 32277346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Type 1 diabetic cardiomyopathy in the Akita (Ins2WT/C96Y) mouse model is characterized by lipotoxicity and diastolic dysfunction with preserved systolic function.
    Basu R; Oudit GY; Wang X; Zhang L; Ussher JR; Lopaschuk GD; Kassiri Z
    Am J Physiol Heart Circ Physiol; 2009 Dec; 297(6):H2096-108. PubMed ID: 19801494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts.
    Makarenko I; Opitz CA; Leake MC; Neagoe C; Kulke M; Gwathmey JK; del Monte F; Hajjar RJ; Linke WA
    Circ Res; 2004 Oct; 95(7):708-16. PubMed ID: 15345656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No contribution of IP3-R(2) to disease phenotype in models of dilated cardiomyopathy or pressure overload hypertrophy.
    Cooley N; Ouyang K; McMullen JR; Kiriazis H; Sheikh F; Wu W; Mu Y; Du XJ; Chen J; Woodcock EA
    Circ Heart Fail; 2013 Mar; 6(2):318-25. PubMed ID: 23258573
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in sarcomere protein genes as a cause of dilated cardiomyopathy.
    Kamisago M; Sharma SD; DePalma SR; Solomon S; Sharma P; McDonough B; Smoot L; Mullen MP; Woolf PK; Wigle ED; Seidman JG; Seidman CE
    N Engl J Med; 2000 Dec; 343(23):1688-96. PubMed ID: 11106718
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness.
    Wu Y; Bell SP; Trombitas K; Witt CC; Labeit S; LeWinter MM; Granzier H
    Circulation; 2002 Sep; 106(11):1384-9. PubMed ID: 12221057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Altered expression of titin and contractile proteins in failing human myocardium.
    Hein S; Scholz D; Fujitani N; Rennollet H; Brand T; Friedl A; Schaper J
    J Mol Cell Cardiol; 1994 Oct; 26(10):1291-306. PubMed ID: 7869390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Advances in the Genetic Basis and Pathogenesis of Sarcomere Cardiomyopathies.
    Yotti R; Seidman CE; Seidman JG
    Annu Rev Genomics Hum Genet; 2019 Aug; 20():129-153. PubMed ID: 30978303
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Substrain specific response to cardiac pressure overload in C57BL/6 mice.
    Garcia-Menendez L; Karamanlidis G; Kolwicz S; Tian R
    Am J Physiol Heart Circ Physiol; 2013 Aug; 305(3):H397-402. PubMed ID: 23709599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypophosphorylation of the Stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium.
    Borbély A; Falcao-Pires I; van Heerebeek L; Hamdani N; Edes I; Gavina C; Leite-Moreira AF; Bronzwaer JG; Papp Z; van der Velden J; Stienen GJ; Paulus WJ
    Circ Res; 2009 Mar; 104(6):780-6. PubMed ID: 19179657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EH-myomesin splice isoform is a novel marker for dilated cardiomyopathy.
    Schoenauer R; Emmert MY; Felley A; Ehler E; Brokopp C; Weber B; Nemir M; Faggian GG; Pedrazzini T; Falk V; Hoerstrup SP; Agarkova I
    Basic Res Cardiol; 2011 Mar; 106(2):233-47. PubMed ID: 21069531
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term miR-669a therapy alleviates chronic dilated cardiomyopathy in dystrophic mice.
    Quattrocelli M; Crippa S; Montecchiani C; Camps J; Cornaglia AI; Boldrin L; Morgan J; Calligaro A; Casasco A; Orlacchio A; Gijsbers R; D'Hooge J; Toelen J; Janssens S; Sampaolesi M
    J Am Heart Assoc; 2013 Aug; 2(4):e000284. PubMed ID: 23963759
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Titin isoforms, extracellular matrix, and global chamber remodeling in experimental dilated cardiomyopathy: functional implications and mechanistic insight.
    Jaber WA; Maniu C; Krysiak J; Shapiro BP; Meyer DM; Linke WA; Redfield MM
    Circ Heart Fail; 2008 Sep; 1(3):192-9. PubMed ID: 19808289
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Titin isoform switch in ischemic human heart disease.
    Neagoe C; Kulke M; del Monte F; Gwathmey JK; de Tombe PP; Hajjar RJ; Linke WA
    Circulation; 2002 Sep; 106(11):1333-41. PubMed ID: 12221049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic urocortin 2 administration improves cardiac function and ameliorates cardiac remodeling after experimental myocardial infarction.
    Ellmers LJ; Scott NJ; Cameron VA; Richards AM; Rademaker MT
    J Cardiovasc Pharmacol; 2015 Mar; 65(3):269-75. PubMed ID: 25658462
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Heart failure with preserved ejection fraction: chronic low-intensity interval exercise training preserves myocardial O2 balance and diastolic function.
    Marshall KD; Muller BN; Krenz M; Hanft LM; McDonald KS; Dellsperger KC; Emter CA
    J Appl Physiol (1985); 2013 Jan; 114(1):131-47. PubMed ID: 23104696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.